Signaling and Reverse Signaling in the Tumor Necrosis Factor/TNF Receptor System

  • Ernő Duda
  • Tünde Nagy
  • Daniela N. Männel
  • Günther Eissner
Part of the Springer Series in Biophysics book series (BIOPHYSICS, volume 8)


Tumor Necrosis Factor Death Domain Nerve Growth Factor Receptor Tumor Necrosis Factor Family Tumor Necrosis Factor Superfamily 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amir RE, Haecker H, Karin M, Ciechanover A (2004) Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase. Oncogene 23(14):2540–2547CrossRefPubMedGoogle Scholar
  2. Arch RH, Gedrich RW, Thompson CB (2000) Translocation of TRAF proteins regulates apoptotic threshold of cells. Biochem Biophys Res Commun 272(3):936–945CrossRefPubMedGoogle Scholar
  3. Banner DW, D’Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W (1993) Crystal structure of the soluble human 55 kD TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73(3):431–445CrossRefPubMedGoogle Scholar
  4. Baud V, Liu ZG, Bennett B, Suzuki N, Xia Y, Karin M (1999) Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev 13(10):1297–1308PubMedGoogle Scholar
  5. Bhardwaj A, Aggarwal BB (2003) Receptor-mediated choreography of life and death. J Clin Immunol 23(5):317–332CrossRefPubMedGoogle Scholar
  6. Bishop GA, Warren WD, Berton MT (1995) Signaling via MHC class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur J Immunol 25:1230–1238PubMedGoogle Scholar
  7. Bishop GA, Hostager BS, Brown KD (2002) Mechanisms of tumor necrosis factor receptor associated factor (TRAF) regulation in B lymphocytes. J Leuk Biol 72:19–23Google Scholar
  8. Bobe J, Goetz FW (2001) Molecular cloning and expression of a TNF receptor and two TNF ligands in the fish ovary. Comp Biochem Physiol B Biochem Mol Biol 129(2–3):475–481CrossRefPubMedGoogle Scholar
  9. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85:803–815CrossRefPubMedGoogle Scholar
  10. Bourgeois C, Rocha B, Tanchot C (2002) A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297:2060–2063CrossRefPubMedGoogle Scholar
  11. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C, Huhse B, Mangano R, Michon AM, Schirle M, Schlegl J, Schwab M, Stein MA, Bauer A, Casari G, Drewes G, Gavin AC, Jackson DB, Joberty G, Neubauer G, Rick J, Kuster B, Superti-Furga G (2004) A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 6(2):97–105CrossRefPubMedGoogle Scholar
  12. Brown KD, Hostager BS, Bishop GA (2001) Differential signaling and TRAF degradation by CD40 and the EBV oncoprotein LMP1. J Exp Med 193:943–954CrossRefPubMedGoogle Scholar
  13. Brown KD, Hostager BS, Bishop GA (2002) Regulation of TRAF2 signaling by self-induced degradation. J Biol Chem 277:19433–19438CrossRefPubMedGoogle Scholar
  14. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK (1993) CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 14:559–564CrossRefPubMedGoogle Scholar
  15. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR (1996) CD40L is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283–289CrossRefPubMedGoogle Scholar
  16. Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV, Karin M (2001) IKKa provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107:763–775CrossRefPubMedGoogle Scholar
  17. Carpentier I, Beyaert R (1999) TRAF1 is a TNF inducible regulator of NF-kappaB activation. FEBS Lett 460(2):246–250CrossRefPubMedGoogle Scholar
  18. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666–3670PubMedGoogle Scholar
  19. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288(5475):2351–2354CrossRefPubMedGoogle Scholar
  20. Chen NJ, Huang MW, Hsieh SL (2001) Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J Immunol 166(1):270–276PubMedGoogle Scholar
  21. Chen PC, DuBois GC, Chen MJ (1995) Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors. J Biol Chem 270(6):2874–2878CrossRefPubMedGoogle Scholar
  22. Chinnaiyan AM, O’Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM (1996) Signal transduction by DR3, a death domain-containing receptor related to TNF-R1 and CD95. Science 274:990–992CrossRefPubMedGoogle Scholar
  23. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN (2001) Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 167(3):1347–1352PubMedGoogle Scholar
  24. Christophides GK, Zdobnov E, Barillas-Mury C, Birney E, Blandin S, Blass C, Brey PT, Collins FH, Danielli A, Dimopoulos G, Hetru C, Hoa NT, Hoffmann JA, Kanzok SM, Letunic I, Levashina EA, Loukeris TG, Lycett G, Meister S, Michel K, Moita LF, Muller HM, Osta MA, Paskewitz SM, Reichhart JM, Rzhetsky A, Troxler L, Vernick KD, Vlachou D, Volz J, von Mering C, Xu J, Zheng L, Bork P, Kafatos FC (2002) Immunity-related genes and gene families in Anopheles gambiae. Science 298(5591):159–165CrossRefPubMedGoogle Scholar
  25. Cottin V, Doan JE, Riches DW (2002) Restricted localization of the TNF receptor CD120a to lipid rafts: a novel role for the death domain. J Immunol 168:4095–4102PubMedGoogle Scholar
  26. Crowe PD, Walter BN, Mohler KM, Otten-Evans C, Black RA, Ware CF (1995) A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 181(3):1205–1210CrossRefPubMedGoogle Scholar
  27. Dadgostar H, Cheng G (2000) Membrane localization of TRAF3 enables JNK activation. J Biol Chem 275:2539–2544CrossRefPubMedGoogle Scholar
  28. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17(4):525–535CrossRefPubMedGoogle Scholar
  29. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G (1996) Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol 16:7098–7108PubMedGoogle Scholar
  30. Devin A, Lin Y, Yamaoka S, Li Z, Karin M, Liu Zg (2001) The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol Cell Biol 21(12):3986–3994CrossRefPubMedGoogle Scholar
  31. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G (1993) CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541–543CrossRefPubMedGoogle Scholar
  32. Domonkos A, Udvardy A, Laszlo L, Nagy T, Duda E (2001) Receptor-like properties of the 26 kDa transmembrane form of TNF. Eur Cytokine Netw 12(3):411–419PubMedGoogle Scholar
  33. Eissner G, Kirchner S, Lindner H, Kolch W, Janosch P, Grell M, Scheurich P, Andreesen R, Holler E (2000) Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol 164(12):6193–6198PubMedGoogle Scholar
  34. Eissner G, Kolch W, Scheurich P (2004) Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 15(5):353–366CrossRefPubMedGoogle Scholar
  35. Feng X, Gaeta ML, Madge LA, Yang JH, Bradly JR, Pober JS (2001) Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J Biol Chem 276(11):8341–8349CrossRefPubMedGoogle Scholar
  36. Ferran C, Dautry F, Merite S, Sheehan K, Schreiber R, Grau G, Bach JF, Chatenoud L (1994) Antitumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J Clin Invest 93(5):2189–2196PubMedGoogle Scholar
  37. Fesik SW (2000) Insights into programmed cell death through structural biology. Cell 103(2):273–282CrossRefPubMedGoogle Scholar
  38. Francis DA, Karras JG, Ke X, Sen R, Rothstein TL (1995) Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol 7:151–161PubMedGoogle Scholar
  39. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen FS, Chatila T, Fu SM, Stamenkovic I, Geha RS (1993) Defective expression of the CD40 ligand in X chromosome-linked Ig deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 90:2170–2173PubMedGoogle Scholar
  40. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K (1998) The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9(1):59–70CrossRefPubMedGoogle Scholar
  41. Galibert L, Tometsko ME, Anderson DM, Cosman D, Dougall WC (1998) The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem 273:34120–34127CrossRefPubMedGoogle Scholar
  42. Gamper C, van Eyndhoven WG, Schweiger E, Mossbacher M, Koo B, Lederman S (2000) TRAF-3 interacts with p62 nucleoporin, a component of the nuclear pore central plug that binds classical NLS-containing import complexes. Mol Immunol 37(1–2):73–84CrossRefPubMedGoogle Scholar
  43. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC (2003) Antitumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3(3):148–155CrossRefPubMedGoogle Scholar
  44. Gedrich RW, Gilfillan MC, Duckett CS, Van Dongen JL, Thompson CB (1996) CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem 271:12852–12858CrossRefPubMedGoogle Scholar
  45. Gordon NC, Pan B, Hymowitz SG, Yin J, Kelley RF, Cochran AG, Yan M, Dixit VM, Fairbrother WJ, Starovasnik MA (2003) BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry 42(20):5977–5983CrossRefPubMedGoogle Scholar
  46. Granger GA, Shacks SJ, Williams TW, Kolb WP (1969) Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin like materials from tuberculin-sensitive lymphoid cells. Nature 221:1155–1157PubMedGoogle Scholar
  47. Gravestein LA, Amsen D, Boes M, Calvo CR, Kruisbeek AM, Borst J (1998) The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur J Immunol 28(7):2208–2216CrossRefPubMedGoogle Scholar
  48. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83(5):793–802CrossRefPubMedGoogle Scholar
  49. Grewal IS, Flavell RA (1996) A central role of CD40L in the regulation of CD4+ T-cell responses. Immunol Today 17:410–414CrossRefPubMedGoogle Scholar
  50. Grewal IS, Xu J, Flavell RA (1995) Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617–620CrossRefPubMedGoogle Scholar
  51. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CA Jr, Flavell RA (1996) Requirement for CD40L in costimulation induction, T cell activation, and EAE. Science 273:1864–1867PubMedGoogle Scholar
  52. Gruss HJ, Dower SK (1995) The TNF ligand superfamily and its relevance for human diseases. Cytokines Mol Ther 1(2):75–105PubMedGoogle Scholar
  53. Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH, Kim HH (2003a) Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. J Biol Chem 278(20):18573–18580CrossRefPubMedGoogle Scholar
  54. Ha H, Kwak HB, Le SW, Kim HH, Lee ZH (2003b) Lipid rafts are important for the association of RANK and TRAF6. Exp Mol Med 35(4):279–284PubMedGoogle Scholar
  55. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet 359(9317):1541–1549CrossRefPubMedGoogle Scholar
  56. Harashima S, Horiuchi T, Hatta N, Morita C, Higuchi M, Sawabe T, Tsukamoto H, Tahira T, Hayashi K, Fujita S, Niho Y (2001) Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol 166(1):130–136PubMedGoogle Scholar
  57. Harless Smith S, Cancro MP (2003) BLyS: the pivotal determinant of peripheral B cell selection and lifespan. Curr Pharm Des 9(23):1833–1847CrossRefPubMedGoogle Scholar
  58. Hehlgans T, Männel DN (2002) The TNF-TNF receptor system. Biol Chem 383(10):1581–1585CrossRefPubMedGoogle Scholar
  59. Hennino A, Berard M, Casamayor-Pallejà M, Krammer PH, Defrance T (2000) Regulation of the Fas death pathway by FLIP in primary human B cells. J Immunol 165:3023–3030PubMedGoogle Scholar
  60. Higuchi M, Aggarwal BB (1994) TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152(7):3550–3558PubMedGoogle Scholar
  61. Hirono I, Nam BH, Kurobe T, Aoki T (2000) Molecular cloning, characterization, and expression of TNF cDNA and gene from Japanese flounder Paralychthys olivaceus. J Immunol 165(8):4423–4427PubMedGoogle Scholar
  62. Hoeflich KP, Yeh WC, Yao Z, Mak TW, Woodgett JR (1999) Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 18(42):5814–5820CrossRefPubMedGoogle Scholar
  63. Hoffmann JA, Reichhart JM (2002) Drosophila innate immunity: an evolutionary perspective. Nat Immunol 3(2):121–126CrossRefPubMedGoogle Scholar
  64. Hollander GA, Castigli E, Kulbacki R, Su M, Burakoff SJ, Gutierrez-Ramos JC, Geha RS (1996) Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc Natl Acad Sci USA 93:4994–4998CrossRefPubMedGoogle Scholar
  65. Holler E, Kolb HJ, Mittermuller J, Kaul M, Ledderose G, Duell T, Seeber B, Schleuning M, Hintermeier-Knabe R, Ertl B, Kempeni J, Wilmanns W (1995) Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). Blood 86:890–899PubMedGoogle Scholar
  66. Horie R, Higashihara M, Watanabe T (2003) Hodgkin’s lymphoma and CD30 signal transduction. Int J Hematol 77(1):37–47PubMedGoogle Scholar
  67. Hostager BS, Catlett IM, Bishop GA (2000) Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem 275(20):15392–15398CrossRefPubMedGoogle Scholar
  68. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387–396CrossRefPubMedGoogle Scholar
  69. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540–3545CrossRefPubMedGoogle Scholar
  70. Hsu KC, Chao MV (1993) Differential expression and ligand binding properties of tumor necrosis factor receptor chimeric mutants. J Biol Chem 268(22):16430–16436PubMedGoogle Scholar
  71. Hu S, Yang X (2000) dFADD, a novel death domain-containing adapter protein for the Drosophila caspase DREDD. J Biol Chem 275(40):30761–30764CrossRefPubMedGoogle Scholar
  72. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, Karin M (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKa subunit of IkB kinase. Science 284:316–320CrossRefPubMedGoogle Scholar
  73. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M (2001) IKKa controls formation of the epidermis independently of NF-κB. Nature 410:710–714CrossRefPubMedGoogle Scholar
  74. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O’Connell M, Kelley RF, Ashkenazi A, de Vos AM (1999) Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4(4):563–571CrossRefPubMedGoogle Scholar
  75. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90–94CrossRefPubMedGoogle Scholar
  76. Igaki T, Kanda H, Yamamoto-Goto Y, Kanuka H, Kuranaga E, Aigaki T, Miura M (2002) Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway. EMBO J 21(12):3009–3018CrossRefPubMedGoogle Scholar
  77. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190–195CrossRefPubMedGoogle Scholar
  78. Ishida TK, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J (1996) TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 93(18):9437–9442CrossRefPubMedGoogle Scholar
  79. Ishikawa H, Claudio E, Dambach D, Raventos-Suarez C, Ryan C, Bravo R (1998) Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J Exp Med 187(7):985–996CrossRefPubMedGoogle Scholar
  80. Jiang Y, Woronicz JD, Liu W, Goeddel DV (1999) Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283:543–546CrossRefPubMedGoogle Scholar
  81. Kaisho T, Takeda K, Tsujimura T, Kawai T, Nomura F, Terada N, Akira S (2001) IkB kinase α is essential for mature B-cell development and function. J Exp Med 193:417–426CrossRefPubMedGoogle Scholar
  82. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H (1996) Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275–281CrossRefPubMedGoogle Scholar
  83. Kanda H, Igaki T, Kanuka H, Yagi T, Miura M (2002) Wengen, a member of the Drosophila tumor necrosis factor receptor superfamily, is required for Eiger signaling. J Biol Chem 277(32):28372–28375CrossRefPubMedGoogle Scholar
  84. Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM (2002) BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 10:515–524CrossRefGoogle Scholar
  85. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8:297–303CrossRefPubMedGoogle Scholar
  86. Khosla S (2003) The OPG/RANKL/RANK system. Endocrinology 142(12):5050–5055CrossRefGoogle Scholar
  87. Khush RS, Leulier F, Lemaitre B (2001) Drosophila immunity: two paths to NF-kappaB. Trends Immunol 22(5):260–264CrossRefPubMedGoogle Scholar
  88. Kirchner S, Boldt S, Kolch W, Haffner S, Kazak S, Janosch P, Holler E, Andreesen R, Eissner G (2004) LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway. J Leukoc Biol 75(2):324–331CrossRefPubMedGoogle Scholar
  89. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579–5588PubMedGoogle Scholar
  90. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A (2000) Apo2L/TRAILdependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611–620CrossRefPubMedGoogle Scholar
  91. Kishore U, Reid KB (2000) C1q: structure, function, and receptors. Immunopharmacology 49(1–2):159–170CrossRefPubMedGoogle Scholar
  92. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539–541CrossRefPubMedGoogle Scholar
  93. Krajewska M, Krajewski S, Zapata JM, Van Arsdale T, Gascoyne RD, Berem K, McFadden D, Shabaik A, Hugh J, Reynolds A, Clevenger CV, Reed JC (1998) TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues. Am J Pathol 152(6):1549–1561PubMedGoogle Scholar
  94. Krammer PH (2000) CD95’s deadly mission in the immune system. Nature 407:789–795CrossRefPubMedGoogle Scholar
  95. Krippner-Heidenreich A, Tubing F, Bryde S, Willi S, Zimmermann G, Scheurich P (2002) Control of receptor-induced signaling complex (RISC) formation by the kinetics of ligand/receptor interaction. J Biol Chem 277(46):44155–44163CrossRefPubMedGoogle Scholar
  96. Lainez B, Fernandez-Real JM, Romero X, Esplugues E, Canete JD, Ricart W, Engel P (2004) Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. Int Immunol 16(1):169–177CrossRefPubMedGoogle Scholar
  97. Laing KJ, Wang T, Zou J, Holland J, Hong S, Bols N, Hirono I, Aoki T, Secombes CJ (2001) Cloning and expression analysis of rainbow trout Oncorhynchus mykiss tumour necrosis factor-α. Eur J Biochem 268:1315–1322CrossRefPubMedGoogle Scholar
  98. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y (1997) TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7(5):703–713CrossRefPubMedGoogle Scholar
  99. Leonardi A, Ellinger-Ziegelbauer H, Franzoso G, Brown K, Siebenlist U (2000) Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2. J Biol Chem 275(1):271–278CrossRefPubMedGoogle Scholar
  100. Leulier F, Vidal S, Saigo K, Ueda R, Lemaitre B (2002) Inducible expression of double-stranded RNA reveals a role for dFADD in the regulation of the antibacterial response in Drosophila adults. Curr Biol 12(12):996–1000CrossRefPubMedGoogle Scholar
  101. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV (1991) Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88(7):2830–2834PubMedGoogle Scholar
  102. Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491–501CrossRefPubMedGoogle Scholar
  103. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2(10):725–734CrossRefPubMedGoogle Scholar
  104. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpusua-Belmonte JC, Verma IM (1999a) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 13:1322–1328PubMedGoogle Scholar
  105. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM (1999b) Severe liver degeneration in mice lacking the IkB kinase 2 gene. Science 284:321–325CrossRefPubMedGoogle Scholar
  106. Li YY, Baccam M, Waters SB, Pessin JE, Bishop GA, Koretzky GA (1996) CD40 ligation results in PKC-independent activation of ERK and JNK in resting murine splenic B cells. J Immunol 157:1440–1447PubMedGoogle Scholar
  107. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M (1999) The IKKb subunit of IkB kinase (IKK) is essential for nuclear factor kB activation and prevention of apoptosis. J Exp Med 189:1839–1845CrossRefPubMedGoogle Scholar
  108. Lin Y, Devin A, Rodriguez Y, Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13:2514–2526CrossRefPubMedGoogle Scholar
  109. Ling L, Goeddel DV (2000) MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule network. J Biol Chem 275(31):23852–23860CrossRefPubMedGoogle Scholar
  110. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501CrossRefPubMedGoogle Scholar
  111. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW (1999) TRAF6 deficiency results in osteo-petrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 13(8):1015–1024PubMedGoogle Scholar
  112. Luftig MA, Cahir-McFarland E, Mosialos G, Kieff E (2001) Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40. J Biol Chem 276(18):14602–14606CrossRefPubMedGoogle Scholar
  113. Lugering A, Schmidt M, Lugering N, Pauels HG, Domschke W, Kucharzik T (2001) Infliximab induces apoptosis in monocytes from patients with chronic active Crohn’s disease by using a caspase-dependent pathway. Gastroenterology 121(5):1145–1157CrossRefPubMedGoogle Scholar
  114. MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14(6):477–492CrossRefPubMedGoogle Scholar
  115. Malinin NL, Boldin MP, Kovalenko AV, Wallach D (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385(6616):540–544CrossRefPubMedGoogle Scholar
  116. Martin SJ (2001) Dealing the CARDs between life and death. Trends Cell Biol 11(5):188–189CrossRefPubMedGoogle Scholar
  117. Maruo S, Oh-hora M, Ahn HJ, Ono S, Wysocka M, Kaneko Y, Yagita H, Okumura K, Kikutani H, Kishimoto T, Kobayashi M, Hamaoka T, Trinchieri G, Fujiwara H (1997) B cells regulate CD40-Linduced IL-12 production in APC during T cell/APC interactions. J Immunol 158:120–126PubMedGoogle Scholar
  118. Matsushima A, Kais ho T, Rennert PD, Nakano H, Kurosawa K, Uchida D, Takeda K, Akira S, Matsumoto M (2001) Essential role of nuclear factor (NF)-kB-inducing kinase and inhibitor of kB (IkB) kinase α in NF-κB activation through lymphotoxin B receptor, but not through tumor necrosis factor receptor I. J Exp Med 193:631–636CrossRefPubMedGoogle Scholar
  119. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, Freeman GJ, Sharpe AH (2001) ICOS is critical for CD40-mediated antibody class switching. Nature 409:102–105CrossRefPubMedGoogle Scholar
  120. McWhirter SM, Pullen SS, Holton JM, Crute JJ, Kehry MR, Alber T (1999) Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci USA 96(15):8408–8413CrossRefPubMedGoogle Scholar
  121. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794–2804CrossRefPubMedGoogle Scholar
  122. Moodycliffe AM, Shreedhar V, Ullrich SE, Walterscheid J, Bucana C, Kripke ML, Flores-Romo L (2000) CD40-CD40L interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med 191:2011–2020CrossRefPubMedGoogle Scholar
  123. Moreno E, Yan M, Basler K (2002) Evolution of TNF signaling mechanisms: JNK-dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF superfamily. Curr Biol 12(14):1263–1268CrossRefPubMedGoogle Scholar
  124. Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, Takamoto M, Nikaido T, Yasui K, Uehara Y, Yachie A, Komiyama A (1998) CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol 161(12):6496–6502PubMedGoogle Scholar
  125. Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH (2003) Infliximab treatment of rheumatoid arthritis and Crohn’s disease. Ann Pharmacother 37(9):1256–1265CrossRefPubMedGoogle Scholar
  126. Naito A, Azuma S, Tanaka S, Miyazaki T, Takasi S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, Inoue J (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4(6):353–362CrossRefPubMedGoogle Scholar
  127. Nakano H, Oshima H, Chung W, Williams-Abbott L, Ware CF, Yagita H, Okumura K (1996) TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J Biol Chem 271(25):14661–14664CrossRefPubMedGoogle Scholar
  128. Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, Ichijo H (1998) ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 2:389–395CrossRefPubMedGoogle Scholar
  129. Nolan B, Kim R, Duffy A, Sheth K, De M, Miller C, Chari R, Bankey P (2000) Inhibited neutrophil apoptosis: proteasome dependent NF-kappaB translocation is required for TRAF-1 synthesis. Shock 14(3):290–294PubMedGoogle Scholar
  130. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815–818CrossRefPubMedGoogle Scholar
  131. Park SM, Kim HS, Choe J, Lee TH (1999) Differential induction of cytokine genes and activation of mitogen-activated protein kinase family by soluble CD40 ligand and TNF in a human follicular dendritic cell line. J Immunol 163(2):631–638PubMedGoogle Scholar
  132. Pfeffer K (2003) Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 14:185–191CrossRefPubMedGoogle Scholar
  133. Pradet-Balade B, Medema JP, Lopez-Fraga M, Lozano JC, Kolfschoten GM, Picard A, Martinez-A C, Garcia-Sanz JA, Hahne M (2002) An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J 21(21):5711–5720CrossRefPubMedGoogle Scholar
  134. Pullen SS, Miller HG, Everdeen DS, Dang TT, Crute JJ, Kehry MR (1998) CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37(34):11836–11845CrossRefPubMedGoogle Scholar
  135. Rabizadeh S, Bredesen DE (2003) Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). Cytokine Growth Factor Rev 14(3–4):225–239CrossRefPubMedGoogle Scholar
  136. Ren CL, Morio T, Fu SM, Geha RS (1994) Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J Exp Med 179:673–680CrossRefPubMedGoogle Scholar
  137. Rennert PD, James D, Mackay F, Browning JL, Hochman PS (1998) Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9(1):71–79CrossRefPubMedGoogle Scholar
  138. Rothe J, Mackay F, Bluethmann H, Zinkernagel R, Lesslauer W (1994) Phenotypic analysis of TNFR1-deficient mice and characterization of TNFR1-deficient fibroblasts in vitro. Circ Shock 44(2):51–56PubMedGoogle Scholar
  139. Saito K, Ohara N, Hotokezaka H, Fukumoto S, Yuasa K, Naito M, Fujiwara T, Nakayama K (2004) Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis. J Biol Chem 279(14):13555–13563CrossRefPubMedGoogle Scholar
  140. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Zon LI (1994) Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372:794–798PubMedGoogle Scholar
  141. Scaffidi C, Krammer PH, Peter ME (1999) Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. Methods 17(4):287–291CrossRefPubMedGoogle Scholar
  142. Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, Wagner C (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301(2):418–426CrossRefPubMedGoogle Scholar
  143. Schwenzer R, Siemienski K, Liptai S, Schubert G, Peters N, Scheurich P, Schmid RM, Wajant H (1999) The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase. J Biol Chem 274(27):19368–19374CrossRefPubMedGoogle Scholar
  144. Seitz C, Muller P, Krieg RC, Männel DN, Hehlgans T (2001) A novel p75TNF receptor isoform mediating NFkappa B activation. J Biol Chem 276(22):19390–19395CrossRefPubMedGoogle Scholar
  145. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway, Science 293(5534):1495–1499CrossRefPubMedGoogle Scholar
  146. Shanahan JC, St Clair W (2002) Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease. Clin Immunol 103 (3 Part 1):231–242CrossRefPubMedGoogle Scholar
  147. Shi C, Leonardi A, Kyriakis J, Siebenlist U, Kehrl JH (1999) TNF-mediated activation of the SAPK pathway: TRAF2 recruits and activates germinal center kinase related. J Immunol 163:3279–3285PubMedGoogle Scholar
  148. Shiels H, Li X, Schumacker PT, Maltepe E, Padrid PA, Sperling A, Thompson CB, Lindsten T (2000) TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs. Am J Pathol 157(2):679–688PubMedGoogle Scholar
  149. Shin HH, Kim SJ, Lee HS, Choi HS (2004) The soluble glucocorticoid-induced tumor necrosis factor receptor causes cell cycle arrest and apoptosis in murine macrophages. Biochem Biophys Res Commun 316(1):24–32CrossRefPubMedGoogle Scholar
  150. Shiozaki EN, Chai J, Shi Y (2002) Oligomerization and activation of caspase-9, induced by Apaf-1 CARD. Proc Natl Acad Sci USA 99:4197–4202CrossRefPubMedGoogle Scholar
  151. Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY, Lenardo MJ (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288(5475):2354–2357CrossRefPubMedGoogle Scholar
  152. Sil AK, Maeda S, Sano Y, Roop DR, Karin M (2004) IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428(6983):660–664CrossRefPubMedGoogle Scholar
  153. Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M (1997) TNF-mediated kinase cascades: bifurcation of NF-kappaB and JNK/SAPK pathways at TRAF2. Proc Natl Acad Sci USA 94:9792–9796CrossRefPubMedGoogle Scholar
  154. Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJ Jr, Ruddle NH, McMahon-Pratt D, Flavell RA (1996) Disruption of CD40-CD40L interactions results in an enhanced susceptibility to Leishmania amazonesis infection. Immunity 4:263–273CrossRefPubMedGoogle Scholar
  155. Speiser DE, Lee SY, Wong B, Arron J, Santana A, Kong YY, Ohashi PS, Choi Y (1997) A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 185(10):1777–1783CrossRefPubMedGoogle Scholar
  156. Spinicelli S, Nocentini G, Ronchetti S, Krausz LT, Bianchini R, Riccardi C (2002) GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. Cell Death Differ 9(12):1382–1384CrossRefPubMedGoogle Scholar
  157. Stanger BZ, Leder P, Lee TH, Kim E, Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513–523CrossRefPubMedGoogle Scholar
  158. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA (1996) Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 156:8–11PubMedGoogle Scholar
  159. Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR (1996) Differential activation of the ERK, JNK, and p38 MAP kinases by CD40 and the B cell antigen receptor. J Immunol 157:3381–3390PubMedGoogle Scholar
  160. Suzuki I, Fink PJ (1998) Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 187(1):123–128CrossRefPubMedGoogle Scholar
  161. Suzuki Y, Nakabayashi Y, Takahashi R (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteosomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 98:8662–8667CrossRefPubMedGoogle Scholar
  162. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, Sanjo H, Yoshikawa K, Terada N, Akira S (1999) Limb and skin abnormalities in mice lacking IKKa. Science 284:313–316CrossRefPubMedGoogle Scholar
  163. Takeuchi M, Rothe M, Goeddel D (1996) Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J Biol Chem 271:19935–19942CrossRefPubMedGoogle Scholar
  164. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV (1999) Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKKB-deficient mice. Immunity 10:421–429CrossRefPubMedGoogle Scholar
  165. Tang G, Yang J, Minemoto Y, Lin A (2001) Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol Cell 8:1005–1016CrossRefPubMedGoogle Scholar
  166. Tartaglia LA, Ayers TM, Wong GH, Goeddel DV (1993) A novel domain within the 55 kD TNF receptor signals cell death. Cell 74(5):845–853CrossRefPubMedGoogle Scholar
  167. ten Hove T, van Montfrans C, Peppelenbosch MP, van Deventer SJ (2002) Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn’s disease. Gut 50(2):206–211CrossRefPubMedGoogle Scholar
  168. Tumanov AV, Kuprash DV, Nedospasov SA (2003) The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev 14:275–288CrossRefPubMedGoogle Scholar
  169. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL (1996) Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor associated factors. Proc Natl Acad Sci USA 93:4974–4978CrossRefPubMedGoogle Scholar
  170. Vandenabeele P, Declercq W, Beyaert R, Fiers W (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5(10):392–393CrossRefPubMedGoogle Scholar
  171. van Deventer SJ (2001) Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn’s disease. Gastroenterology 121(5):1242–1246PubMedGoogle Scholar
  172. Vandevoorde V, Haegeman G, Fiers W (1997) Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects. J Cell Biol 137(7):1627–1638CrossRefPubMedGoogle Scholar
  173. van Essen D, Kikutani H, Gray D (1995) CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620–623CrossRefGoogle Scholar
  174. von Tresckow B, Kallen KJ, von Strandmann EP, Borchmann P, Lange H, Engert A, Hansen HP (2004) Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. J Immunol 172(7):4324–4331PubMedGoogle Scholar
  175. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346–351CrossRefPubMedGoogle Scholar
  176. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281(5383):1680–1683CrossRefPubMedGoogle Scholar
  177. Wang J, Lobito AA, Shen F, Hornung F, Winoto A, Lenardo MJ (2000) Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 30:155–163CrossRefPubMedGoogle Scholar
  178. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14:2060–2071PubMedGoogle Scholar
  179. Wheller K, Pound JD, Gordon J, Jefferis R (1993) Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur J Immunol 23:1165–1168PubMedGoogle Scholar
  180. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4(6):1041–1049CrossRefPubMedGoogle Scholar
  181. Yamamoto H, Kishimoto T, Minamoto S (1998) NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27. J Immunol 161(9):4753–4759PubMedGoogle Scholar
  182. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB (2003) Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423:655–659CrossRefPubMedGoogle Scholar
  183. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ (1994) Activation of SAPK by MEKK1 phosphorylation of its activator SEK1. Nature 372:798–800PubMedGoogle Scholar
  184. Yang X, Chang HY, Baltimore D (1998) Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell 1:319–325CrossRefPubMedGoogle Scholar
  185. Ye X, Mehlen P, Rabizadeh S, VanArsdale T, Zhang H, Shin H, Wang JJ, Leo E, Zapata J, Hauser CA, Reed JC, Bredesen DE (1999) TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem 274(42):30202–30208CrossRefPubMedGoogle Scholar
  186. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW (1997) Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715–725CrossRefPubMedGoogle Scholar
  187. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD (2001) Defective LT-α receptor-induced NF-κB transcriptional activity in NIK-deficient mice. Science 291:2162–2165CrossRefPubMedGoogle Scholar
  188. Yuasa T, Ohno S, Kehrl JH, Kyriakis JM (1998) TNF signaling to SAPK/JNK and p38. Germinal center kinase couples TRAF2 to MAPK/ERK kinase kinase-1 and SAPK while RIP associates with a MAPKKK upstream of MKK6 and p38. J Biol Chem 273:22681–22692CrossRefPubMedGoogle Scholar
  189. Yujiri T, Ware M, Widmann C, Oyer R, Russell D, Chan E, Zaitsu Y, Clarke P, Tyler K, Oka Y, Fanger GR, Henson P, Johnson GL (2000) MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci USA 97(13):7272–7277CrossRefPubMedGoogle Scholar
  190. Zhu N, Ramirez LM, Lee RL, Magnuson NS, Bishop GA, Gold MR (2002) CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-κB pathway. J Immunol 168:744–754PubMedGoogle Scholar
  191. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405–413CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Ernő Duda
  • Tünde Nagy
  • Daniela N. Männel
  • Günther Eissner

There are no affiliations available

Personalised recommendations